Last reviewed · How we verify
e-Device
At a glance
| Generic name | e-Device |
|---|---|
| Also known as | Cimzia |
| Sponsor | UCB Biopharma S.P.R.L. |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic and Subjective Effects of Heated Tobacco Products (NA)
- Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) (NA)
- The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (NA)
- Flexibility, Alcohol Misuse, and Excitation (NA)
- Impact of E-cigarette Use on the Body
- Exploration of Current and New Technologies for Accuracy of Diagnosing OSA
- Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction (NA)
- Berlin Registry of Right Heart Interventions
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- e-Device CI brief — competitive landscape report
- e-Device updates RSS · CI watch RSS
- UCB Biopharma S.P.R.L. portfolio CI